JAMES MOGHTADER: Open Payments
NPI 1568475424 · SANTA BARBARA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,849 in 84 payments from 15 companies in 2025. Trend: 2023 $5,404 · 2024 $5,711 · 2025 $1,849
Food & beverage: $1,737Education: $111
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 13 | $284 |
| ABBVIE INC. | 22 | $279 |
| Teva Pharmaceuticals USA, Inc. | 7 | $227 |
| Vanda Pharmaceuticals Inc. | 8 | $170 |
| Alkermes, Inc. | 7 | $153 |
| Brainsway USA INC | 1 | $136 |
| Neurocrine BioSciences, Inc. | 4 | $117 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $115 |
| Almatica Pharma LLC | 5 | $90 |
| Otsuka America Pharmaceutical, Inc. | 3 | $71 |
Products named: COBENFY, VRAYLAR, FANAPT, Deep TMS System, ARISTADA, INGREZZA, AUSTEDO XR, CAPLYTA.
Industry payments across CA — which companies pay providers there.
